Description
Follistim AQ (follitropin beta injection) is a prescription medication used to treat infertility in men and women. It contains a hormone called follicle-stimulating hormone (FSH), which helps stimulate the development of follicles in the ovaries and spermatogenesis in the testes.
Follistim AQ is available in a prefilled pen and is administered by injection under the skin.
Fact Table |
Formula |
C975H1513N267O304S26 |
License |
US FDA |
Bioavailability |
77% |
Legal status |
Rx-Only |
Chemical Name |
Follitropin beta |
Elimination half-life |
26.9–43.9 h |
Dosage (Strength) |
- |
Pregnancy |
Contraindicated |
Brands |
Follistim AQ |
Protein binding |
Not available |
PubChem CID |
Not available |
MedlinePlus |
Not available |
ChEBI |
Not available |
ATC code |
G03GA05 |
DrugBank |
DB00066 |
KEGG |
D04430 |
Routes of administration |
Subcutaneous injection |
Directions
Your dosage and frequency will depend on various factors, including what condition you are treating.
For women, Follistim AQ is typically injected subcutaneously once daily with a slowly increasing dose based on response.
For men, Follistim AQ is usually injected two or three times weekly in combination with hCG for at least 3-4 months.
Ingredients
The active ingredient in Follistim AQ is follitropin beta, a recombinant form of FSH produced using genetic engineering technology.
Interactions
- There are no known significant interactions.
Cautions
Tell your doctor if you have a history of ovarian cysts, uterine fibroids, endometriosis, or other conditions that may be affected by hormonal changes.
Follistim AQ may increase the risk of multiple pregnancies, which can be associated with increased health risks for both the mother and infants.
Your doctor will closely monitor the ovarian response to Follistim AQ, as excessive stimulation can lead to ovarian hyperstimulation syndrome (OHSS). Symptoms of OHSS include abdominal pain, bloating, nausea, and vomiting.
Side Effects
The most common adverse effects of this drug include the following:
- Abdominal distension
- Abdominal distress
- Abdominal pain
- Acne vulgaris
- Breast tenderness
- Constipation
- Dermoid cyst
- Diarrhea
- Fatigue
- Gynecomastia
- Headache
- Injection site reaction
- Lower abdominal pain
- Nausea
- Ovarian cyst
- Ovarian hyperstimulation
- Ovarian neoplasm
- Ovarian torsion
- Ovary enlargement
- Pain at the injection site
- Pelvic discomfort
- Pelvic pain
- Skin rash
- Spontaneous abortion
- Thromboembolism
- Uterine hemorrhage
- Vaginal hemorrhage
If you experience any of the above, tell your healthcare team immediately.
References
Follistim AQ [package insert]. West Orange, NJ: Organon USA Inc.; 2004.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 10149